DK1526848T3 - Opiod receptor antagonists in transdermal systems with buprenorphine - Google Patents

Opiod receptor antagonists in transdermal systems with buprenorphine

Info

Publication number
DK1526848T3
DK1526848T3 DK03775130T DK03775130T DK1526848T3 DK 1526848 T3 DK1526848 T3 DK 1526848T3 DK 03775130 T DK03775130 T DK 03775130T DK 03775130 T DK03775130 T DK 03775130T DK 1526848 T3 DK1526848 T3 DK 1526848T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
buprenorphine
transdermal systems
opiod receptor
opiod
Prior art date
Application number
DK03775130T
Other languages
Danish (da)
Inventor
Johannes Bartholomaeus
Heinrich Kugelmann
Eric-Paul Paques
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002137057 external-priority patent/DE10237057A1/en
Priority claimed from DE2002137056 external-priority patent/DE10237056A1/en
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1526848T3 publication Critical patent/DK1526848T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to opioid-receptor antagonists such as, for example, naloxone in transdermal forms of administration at least containing buprenorphine as an active principle.
DK03775130T 2002-08-09 2003-08-08 Opiod receptor antagonists in transdermal systems with buprenorphine DK1526848T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2002137057 DE10237057A1 (en) 2002-08-09 2002-08-09 Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential
DE2002137056 DE10237056A1 (en) 2002-08-09 2002-08-09 Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential
PCT/EP2003/008828 WO2004014336A2 (en) 2002-08-09 2003-08-08 Opioid-receptor antagonists in transdermal systems having buprenorphine

Publications (1)

Publication Number Publication Date
DK1526848T3 true DK1526848T3 (en) 2007-10-22

Family

ID=31716605

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03775130T DK1526848T3 (en) 2002-08-09 2003-08-08 Opiod receptor antagonists in transdermal systems with buprenorphine

Country Status (9)

Country Link
EP (1) EP1526848B1 (en)
AT (1) ATE367155T1 (en)
AU (1) AU2003283055A1 (en)
CY (1) CY1107739T1 (en)
DE (1) DE50307717D1 (en)
DK (1) DK1526848T3 (en)
ES (1) ES2290512T3 (en)
PT (1) PT1526848E (en)
WO (1) WO2004014336A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME02661B (en) * 2004-02-23 2017-06-20 Euro Celtique Sa Abuse resistance opioid transdermal delivery device
DE102004019916A1 (en) * 2004-04-21 2005-11-17 Grünenthal GmbH Anti-abuse drug-containing patch
DE102006054731B4 (en) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for administration of the active ingredient buprenorphine and use thereof in pain therapy
GB2447015A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Analgesic composition comprising a specific ratio of buprenorphine and naltrexone
GB2447016A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Buprenorphine/naloxone compositions
JP2011515495A (en) * 2008-03-26 2011-05-19 オールトランツ インコーポレイティド Opiate agonists and agonist-antagonist abuse control transdermal preparations
WO2013088254A1 (en) * 2011-12-12 2013-06-20 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system comprising buprenorphine
EP2810646B1 (en) 2013-06-04 2016-07-27 LTS LOHMANN Therapie-Systeme AG Transdermal delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939376C1 (en) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
WO1997033566A2 (en) * 1996-03-12 1997-09-18 Alza Corporation Composition and dosage form comprising opioid antagonist
JPH1036265A (en) * 1996-07-19 1998-02-10 Nitto Denko Corp Buprenorphine percutaneous absorption preparation
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine

Also Published As

Publication number Publication date
CY1107739T1 (en) 2013-04-18
AU2003283055A1 (en) 2004-02-25
AU2003283055A8 (en) 2004-02-25
DE50307717D1 (en) 2007-08-30
EP1526848A2 (en) 2005-05-04
ES2290512T3 (en) 2008-02-16
ATE367155T1 (en) 2007-08-15
WO2004014336A3 (en) 2004-12-09
PT1526848E (en) 2007-08-08
EP1526848B1 (en) 2007-07-18
WO2004014336A2 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
CY1107739T1 (en) Opioid Receptor Competitors in Buprenorphine Intercostal Systems
ATE388707T1 (en) OPIOID ANTAGONIST COMPOSITION FOR INCREASE THE ANALGESIC EFFECTIVENESS OF TRAMADOL AND REDUCING ITS SIDE EFFECTS
GB0115862D0 (en) Compounds
ATE430747T1 (en) 2-PYRIMIDINYL-PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS
BRPI0510170B8 (en) compound, pharmaceutical composition for the treatment of diseases mediated by the muscarinic acetylcholine receptor and use of the compound
NO20052739D0 (en) CCR5 antagonists as drugs
NO983431D0 (en) Anti-kl ° emidler
ATE384050T1 (en) BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS
PT1379520E (en) NMDA / NR2B NON-SUBSTITUTED ANTAGONISTS (NAO-ARIL) -HETEROCYCLICS
HK1120442A1 (en) Novel opioid antagonists
MY142044A (en) Endoparasiticidal compositions for topical application
IS8377A (en) Arylindenopyridine and arylindenopyrimidine and their use as antagonists of the A2A adenosine receptor
SE0202598D0 (en) Alpha-7 Nicotinic receptor agonists and statins in combination
ATE418548T1 (en) SUBSTITUTED 3-CYANOTHIOPHENE ACETAMIDE AS GLUCAGON RECEPTOR ANTAGONISTS
DE602007012313D1 (en) 5-PHENYL-6-PYRIDINE-4-YL-1,3-DIHYDRO-2H-IMIDAZOE4,5-BÜPYRIDIN-2-ONDERIVES SUITABLE AS A2B ADENOSINE RECEPTOR ANTAGONISTS
TNSN07015A1 (en) Kynurenic acid amide derivatives as nr2b receptor antagonists
TW200621785A (en) Analgesic
HK1077827A1 (en) Diazabicyclononane and-decane derivatives their use as opioid receptor ligands
CY1109803T1 (en) PHARMACEUTICAL COMPOSITES BASED ON NK2 COMPONENTS FOR PEDIATRIC USE
AU2003226765A1 (en) Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
DK1420789T3 (en) Use of active substances with myopioid receptor agonist and opioid receptor antagonist effect as combination drugs for cancer treatment
BRPI0510407A (en) 3-amino-2-phenylpyrrolidine derivatives
EA200300850A1 (en) APPLICATION OF ANTAGONISTS OF GAL3 RECEPTOR IN THE TREATMENT OF DEPRESSION AND / OR ALARM AND CONNECTIONS, USEFUL IN SUCH METHODS
BRPI0416154A (en) combination of t1, amiloride or triamterine antagonists, and a diuretic